These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3195360)

  • 1. Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
    Kontaxakis VP; Christodoulou GN; Markidis MP; Havaki-Kontaxaki BJ
    Acta Psychiatr Scand; 1988 Sep; 78(3):396-8. PubMed ID: 3195360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome--a case report].
    Lanczik M; Fritze J
    Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome.
    Rampertaap MP
    South Med J; 1986 Mar; 79(3):331-6. PubMed ID: 3513330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome presenting without initial fever: a case report.
    Totten VY; Hirschenstein E; Hew P
    J Emerg Med; 1994; 12(1):43-7. PubMed ID: 8163804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
    Cape G
    Br J Psychiatry; 1994 Jan; 164(1):120-2. PubMed ID: 8137093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F; Risse A
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report.
    Tsai MC; Huang TL
    Chang Gung Med J; 2010; 33(5):576-80. PubMed ID: 20979709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.
    Spivak B; Gonen N; Mester R; Averbuch E; Adlersberg S; Weizman A
    Int Clin Psychopharmacol; 1996 Sep; 11(3):207-9. PubMed ID: 8923101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
    Abramova LI; Gushanskiĭ EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):419-24. PubMed ID: 3705854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
    Soni SD; Sampath G; Shah A; Krska J
    Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of neuroleptic malignant syndrome successfully treated with amantadine.
    McCarron MM; Boettger ML; Peck JJ
    J Clin Psychiatry; 1982 Sep; 43(9):381-2. PubMed ID: 7118846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
    Kontaxakis VP; Vaidakis NM; Christodoulou GN; Valergaki HC
    Neuropsychobiology; 1990; 23(1):38-40. PubMed ID: 2280828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent neuroleptic malignant syndrome with clozapine and lithium.
    Pope HG; Cole JO; Choras PT; Fulwiler CE
    J Nerv Ment Dis; 1986 Aug; 174(8):493-5. PubMed ID: 3090198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Gönner F; Baumgartner R; Schüpbach D; Merlo MC
    Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.